{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:38:49Z","timestamp":1792471129189,"version":"4.5.0"},"reference-count":55,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Icodec is the first once\u2010weekly basal insulin for type 2 diabetes (T2D), potentially improving quality of life through a reduced administration burden versus once\u2010daily basal insulins. This study assessed the long\u2010term cost\u2010effectiveness of icodec versus glargine U100, degludec and a mix of once\u2010daily basal insulins (degludec, glargine U100 and glargine U300) in insulin\u2010na\u00efve adults with T2D in Italy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Outcomes were projected over patient lifetimes (up to 60\u2009years) using the PRIME T2D Model, discounted annually at 3.0%. Baseline characteristics and treatment effects were taken from ONWARDS 1, 3 and 5. Modelled patients received basal insulins for 4\u2009years, before intensifying with the addition of bolus insulin. Treatment effects applied in the first year of the analysis and a utility benefit relating to once\u2010weekly versus once\u2010daily injection were maintained until intensification. Costs were expressed in 2024 euros (EUR) from the perspective of the Italian National Health Service.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Icodec was associated with improved quality\u2010adjusted life expectancy of 0.16 quality\u2010adjusted life years (QALYs) versus glargine U100 and degludec, and 0.26 QALYs versus the once\u2010daily insulin mix. Benefits primarily resulted from the reduced injection frequency with icodec. Higher acquisition costs with icodec were partially offset by reduced use of consumables and modelled reductions in diabetes\u2010related complications. Icodec was associated with incremental cost\u2010effectiveness ratios of EUR 25\u2009623, EUR 5438 and EUR 3940 per QALY gained versus glargine U100, degludec and the once\u2010daily insulin mix, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Icodec was projected to be cost\u2010effective versus once\u2010daily insulins for insulin\u2010na\u00efve people with T2D in Italy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.71144","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:59:42Z","timestamp":1785545982000},"page":"9483-9492","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Projecting the Long\u2010Term Cost\u2010Effectiveness of Once\u2010Weekly Insulin Icodec Versus Once\u2010Daily Basal Insulin Analogs in Italy Using the Prime T2D Model"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1306-7784","authenticated-orcid":false,"given":"Samuel J. P.","family":"Malkin","sequence":"first","affiliation":[{"name":"Ossian Health Economics and Communications  Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3451-0121","authenticated-orcid":false,"given":"Saikrishna","family":"Kandalam","sequence":"additional","affiliation":[{"name":"Novo Nordisk Global Business Services  Bengaluru India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7979-9227","authenticated-orcid":false,"given":"Giorgia","family":"Guareschi","sequence":"additional","affiliation":[{"name":"Novo Nordisk S.p.A.  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9930-9507","authenticated-orcid":false,"given":"Lucia S.","family":"D'Angiolella","sequence":"additional","affiliation":[{"name":"Novo Nordisk S.p.A.  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5420-279X","authenticated-orcid":false,"given":"Barnaby","family":"Hunt","sequence":"additional","affiliation":[{"name":"Ossian Health Economics and Communications  Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"e_1_2_12_2_1","unstructured":"International Diabetes Federation (IDF) \u201cIDF Diabetes Atlas\u201411th Edition \u201daccessed March 31 2026 https:\/\/diabetesatlas.org\/."},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110672"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2022.01.026"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1988.tb01003.x"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60576-4"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7160.703"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60104-X"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706245"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0034"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042018821997320"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-022-01470-w"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.2147\/PROM.S322390"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042018819844694"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf229"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303208"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.11313"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.7326\/M23-1288"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.9.2262"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2022.2035132"},{"key":"e_1_2_12_22_1","article-title":"First Italian Guidelines for the Economic Evaluation of Health Technologies: How Do They Compare to NICE Standards","volume":"14","author":"Fiorentino F.","year":"2021","journal-title":"GIHTAD"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-2940-y"},{"key":"e_1_2_12_24_1","unstructured":"World Health Organization \u201cGlobal Health Observatory Data Repository: Life Tables by Country (Italy) \u201d2020 accessed December 10 2021 https:\/\/apps.who.int\/gho\/data\/view.main.LT62260?lang=en."},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12626"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802743"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808431"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905479"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615692"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00520-2"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07650711"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2019.01.010"},{"key":"e_1_2_12_33_1","unstructured":"Ministero della Salute \u201cItalian Diagnosis\u2010Related Groups (DRGs) \u201d2025 accessed May 8 2025 http:\/\/www.salute.gov.it\/portale\/temi\/p2_6.jsp?lingua=italiano&id=3662&area=programmazioneSanitariaLea&menu=vuoto."},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1669613"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S470728"},{"key":"e_1_2_12_36_1","unstructured":"Italian National Statistics Institute \u201cNic\u2014Annual Average From 2016 Onwards \u201d2025 accessed August 15 2025 https:\/\/www.istat.it\/en\/statistical\u2010themes\/economy\/prices\/?data\u2010and\u2010indicators."},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-024-02878-x"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.10.010"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2016.12.019"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-019-00775-8"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.910"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-300726"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13547"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-90"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.10.004"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-022-01215-w"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.06.012"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0331"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-025-01729-4"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-024-01553-w"},{"key":"e_1_2_12_51_1","unstructured":"Novo Nordisk \u201cLife Cycle Assessments. Annual Treatment With FlexTouch. Carbon Footprint Report \u201d2025 accessed November 10 2025 https:\/\/www.novonordisk.com\/content\/dam\/nncorp\/global\/en\/sustainable\u2010business\/pdfs\/esg\u2010portal\/lca\/2025\u2010annual\u2010treatment\u2010flextouch\u2010v1.1.pdf."},{"issue":"1","key":"e_1_2_12_52_1","first-page":"1","article-title":"Health Technology Assessment di Icodec per la gestione dei pazienti affetti da diabete in Italia","volume":"12","author":"Basile M.","year":"2024","journal-title":"Altems Advisory"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcdhc.2023.1293926"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13072113"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S159620"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-025-02619-8"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.71144","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.71144","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.71144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:50:42Z","timestamp":1792468242000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/10.1111\/dom.71144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/dom.71144"],"URL":"https:\/\/doi.org\/10.1111\/dom.71144","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.71144\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71144\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71144\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71144\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71144\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71144\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71144\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71144\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.71144\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"2026-05-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}